By John Russell
February 18, 2004 | International Data Corp. (IDC), a leading provider of IT market data, has jumped into the life science market with the February launch of Life Science Insights (LSI), a subsidiary focused on providing market and technology intelligence to life science companies.
“Biological complexity has raised the IT bar, and life science companies need to overcome the information hurdles to more quickly and effectively deliver the next wave of scientific achievements, and hence a new generation of therapeutics,” stated Paul Gillyon, LSI chief operating officer and managing director, in a press release. “Our mission is to help our clients more intelligently comprehend their unique and evolving opportunities so they can make fact-based decisions and become more successful and competitive in the marketplace.”
Gillyon joins LSI from PerkinElmer, where he was vice president and general manager of its biopharmaceutical business. James Golden, LSI’s vice president of research, had a brief stint at Cambridge Healthtech Institute Insights; prior to that he was business development manager at 454 Corp., and director of bioinformatics at CuraGen.
LSI will work with pharmaceutical and biotech companies as well as life science tools and IT vendors and professional services companies. Initial services include:
- Market sizing and forecasts (The Green Book)
- Subscription-based continuous intelligence services (CIS)
- Leading indicator and benchmarking studies
- Consulting and custom research
IT vendors also represent a key customer segment, according to the company. “Relatively few IT suppliers have implemented effective strategies for meeting the needs of the unique life science end-user audience … They will need special knowledge of the biological and growing IT requirements to sell successfully to companies in the early stages of drug discovery and development,” stated the release.
IDC is a subsidiary of International Data Group, publisher of of Bio-IT World magazine.